JohnG.QuigleyMD

Clinical Trials

• Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Dec 14

  Completed

  Phase 2

• Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04

  Active, not recruiting

  Phase 3

• AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients Start of enrollment: 2015 Jun 05

  Terminated

  Phase 1, Phase 2

• Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 Start of enrollment: 2019 Sep 06

  Active, not recruiting

  Phase 1

  Roles: Sponsor-Investigator, Contact, Principal Investigator

• Novel Experimental COVID-19 Therapies Affecting Host Response Start of enrollment: 2021 Jul 15

  Completed

  Phase 2, Phase 3

  Roles: Contact

• Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) Start of enrollment: 2022 Jun 21

  Recruiting

  Phase 1

  Roles: Contact, Principal Investigator

• Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15

  Recruiting

  Phase 3

  Roles: Contact

• Join now to see all